By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


BioCancell Therapeutics 

Beck Science Center
8 Hartom Street, Har Hotzvim
Jerusalem    97775  Israel
Phone: 972-2-548-6555 Fax: 972-2-548-6550



Company News
BioCancell Therapeutics Announces Appointment Of Ms. Ruti Alon To Board Of Directors 8/14/2017 8:24:00 AM
Cobra Biologics Ltd. And BioCancell Therapeutics Announce Agreement To Manufacture Promising Cancer Therapy Drug 3/3/2014 10:21:52 AM
BioCancell Therapeutics to Commence Enrollment of Phase IIb Pancreatic Cancer Clinical Trial 10/6/2011 10:17:17 AM
BioCancell Therapeutics Successfully Raises $5.1 Million in Public Offering 11/23/2010 6:59:09 AM
Tikcro Technologies Announces Results of BioCancell Therapeutics' US FDA Phase I/IIa Pancreatic Cancer Trial 11/2/2010 10:17:46 AM
BioCancell Therapeutics Announces Success in Phase I/IIa Pancreatic Cancer Clinical Trial 11/1/2010 11:42:47 AM
Tikcro Technologies Announced BioCancell Therapeutics Receives U.S. FDA Approval to Continue Phase IIb Superficial Bladder Cancer Clinical Trial and Interim Results 4/30/2010 11:04:30 AM
US Department of Health and Human Services Grants Orphan Drug Status to BioCancell Therapeutics's Ovarian Cancer Drug 8/24/2009 10:57:06 AM
USA FDA Allows BioCancell Therapeutics to Commence Phase I/IIa Ovarian and Pancreatic Clinical Trials 1/14/2009 10:21:21 AM
VGX International Signs a Master Product Sale Agreement with BioCancell Therapeutics of Israel to Supply Plasmid for Its Multiple Clinical Programs 10/27/2008 11:17:26 AM